MELATONIN EXCHANGE AT MULTIMORBID CARDIOVASCULAR PATHOLOGYWITH ANXIETY AND DEPRESSIVE DISORDERS IN YOUNG AND MIDDLE-AGED MEN



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Evaluate melatonin (MT) patterns excretion at multimorbid cardiovascular pathology (MCVP) (coronary artery disease (CAD), hypertension, metabolic syndrome (MS)) with non-psychot- ic mental disorders (NPMD) anxiety/ depressive type. Identify the effectiveness of visual-auditory ef- fects in the treatment of these pathologies. Design and methods: The study included 70 men (mean age 37,46±6,74) with MCVP divided into 4 groups by simple random sampling, and 20 healthy men (mean age 38,3±6,73 g). Patients in Group 1 (n = 22) received standard therapy CAD, hypertension and NPMD, in group 2 (n = 25) standard therapy CAD, hypertension, NPMD and visual-auditory correction. Patients of group 3 (n = 23) received standard therapy CAD, hypertension, NPMD, visual-auditory correction and psychotherapy. Used in the study: complex psychological test methods and laboratory-instrumental evaluation of the cardiovascular system. Definition of 6-sulfatoxymelatonin (6-SMT) performed by ELI- SA using kits BÜHLMANNEK-M6S. Results: Identified change normal «dipper» pattern to «non- dip- per» and «night-peaker» (daily index blood pressure and 0-10% <0% (p <0,001) in all treatment groups. Patients 3 group observed achievement reference values of the night excretion after treatment 458±64-» 798±32 (before and after treatment, respectively) (p <0,001). In all groups after treatment was observed significantly change the type of NDP «severe depression», «clinical anxiety» to «mild depression»; «sub- clinical anxiety» (p <0,001). Conclusions: Patients with MCVP have abnormalities of MT content char- acterized by a decrease in nocturnal excretion of 6-SMT. Night pattern of 6-SMT excretion significantly correlated with severity of anxiety/ depression before and after treatment. Results of patients treated with visual auditory correction significantly better than patients of other groups (obtained reference intervals MT excretion, biochemical indices and normalization of psychological tests).

Full Text

Restricted Access

About the authors

M A Aflitonov

North-West State Medical University named after I.I. Mechnikov

S A Partsernyak

North-West State Medical University named after I.I. Mechnikov; City hospital №15, Saint-Petersburg

A N Mironenko

North-West State Medical University named after I.I. Mechnikov; City hospital №15, Saint-Petersburg

A S Partsernyak

Military Medical Academy named after S.M. Kirov

A A Topanova

North-West State Medical University named after I.I. Mechnikov

References

  1. Scheidt-Nave C., Richter S., Fuchs J., Kuhlmey A. Challenges to health research for aging populations using the example of «multimorbidity». Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. - 2010. - Vol. 53. - № 5. - P. 441- 50.
  2. Оганов Р.Г., Ольбинская Л.И., Смулевич А.Б., Дробижев М.Ю., Шальнова С.А., Погосова Г.В. Депрессии и расстройства депрессивного спектра в общемедицинской практике. Результаты программы КОМПАС // Кардиология. - 2004. - № 1. - P. 48-54.
  3. Paredes S.D., Forman K.A., García C., Vara E., Escames G., Tresguerres J.A. Protective actions of melatonin and growth hormone on the aged cardiovascular system // Hormone molecular biology and clinical investigation. - 2014. - Vol. 18. - № 79. - P. 1868-1891.
  4. Fabbian F., Smolensky M.H., Tiseo R., Pala M., Manfredini R., Portaluppi F. Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms // Chronobiology International. - 2013. - Vol. 30. - № 1. - P. 17-30.
  5. Hermida R.C., Ayala D.E., Smolensky M.H. Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders // Current Hypertension Reports. - 2014. - Vol.16. - № 2. - P. 412.
  6. Forman K., Vara E., García C., Kireev R., Cuesta S., Acuña-Castroviejo D. Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging // Journal of Pineal Research. - 2010. - Vol. 49. - № 3. - P. 312-20.
  7. Zephy D., Ahmad J. Type 2 diabetes mellitus: Role of melatonin and oxidative stress // Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. - 2015. - Vol. 9. - № 2. - P. 127-131.
  8. Obayashi K., Saeki K., Kurumatani N. Higher melatonin secretion is associated with lower leukocyte and platelet counts in the general elderly population: the HEIJO-KYO cohort // Journal of Pineal Research. - 2015. - Vol. 58. - № 2. - P. 227- 33.
  9. Pechanova O., Paulis L., Simko F. Peripheral and central effects of melatonin on blood pressure regulation // International Journal of Molecular Sciences. - 2014. - Vol. 15. - № 10. - P. 37.
  10. Anderson G., Maes M. Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. // Current Psychiatry Reports. - 2015. - Vol. 17. - № 2. - P. 8.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Aflitonov M.A., Partsernyak S.A., Mironenko A.N., Partsernyak A.S., Topanova A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 71733 от 08.12.2017.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies